Patents Assigned to ENDOTHEL PHARMA APS
  • Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
    Patent number: 11714094
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: August 1, 2023
    Assignee: Endothel Pharma ApS
    Inventors: Sisse Rye Ostrowski, Pär Ingemar Johansson
  • Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
    Patent number: 10527633
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: January 7, 2020
    Assignee: ENDOTHEL PHARMA APS
    Inventors: Sisse Rye Ostrowski, Pär Ingemar Johansson